ARCHIVES

51% Control Rate Achieved In Phase II Trial of Elderly Patients

This article is from The Cancer Letter archive.

Vol. 36 No. 3 | March 29, 2013

Download PDF Visit The Full Archive

Related Articles

Trial: Decitabine Improves Survival in Myeloid Leukemia

July 29, 2011

In Brief: Subcommittee Adds $16-18 Million o NVI Budget; Upton Might Leave If Bill Fails

May 25, 1979

In Brief: Wynder Receives ACS Award At ASCO; Brinker to Be Honored for Public Service

May 23, 1997

Turmoil in Texas: SEC Issues Subpoena to AVEO on Tivozanib

July 12, 2013

In Brief: NCI Award 14 Contracts to Operate The Cancer Information Service

August 13, 1999

IOM Finds Insufficient Evidence to Link Polio Vaccine, Cancer

October 25, 2002